VERBEKE, Geert

Email Alert RSS Feed

Profile

Full Name
VERBEKE, Geert
Email
geert.verbeke@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2020 TO 2021]
Date Issued:  2021

Results 1-8 of 8 (Search time: 0.003 seconds).

Issue DateTitleContributor(s)TypeCat.
12021Corrigendum to “itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens”Liesenborghs, Laurens; Spriet, Isabel; Jochmans, Dirk; Belmans, Ann; Gyselinck, Iwein; Teuwen, Laure-Anne; ter Horst, Sebastiaan; Geukens, Tatjana; Engelen, Matthias M.; Landeloos, Ewout; Geldhof, Vincent; Ceunen, Helga; Debaveye, Barbara; Linden, Lorenz Van der; JACOBS, Sofie; Boudewijns, Robbert; Do, Thuc Nguyen Dan; Chiu, Winston; Weynand, Birgit; Vanassche, Thomas; Meyfroidt, Geert; JANSSENS, Wim; Vos, Robin; Vermeersch, Pieter; Wauters, Joost; VERBEKE, Geert; Kaptein, Suzanne J. F.; Rocha-Pereira, Joana; Van Wijngaerden, Eric; Neyts, Johan; Verhamme, Peter; Dreesen, Erwin; Vandenberk, Bert; Zhang, Xin; Wang, Xinyu; Devos, Timothy; De Munter, Paul; Delang, Leen; Langendries, LanaJournal ContributionA1
22021Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trialGyselinck, I; Liesenborgs , L; Landeloos, E; Belmans, A; VERBEKE, Geert; Verhamme, P; VOS, R; Janssens , WJournal ContributionA1
32021Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-ofconcept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trialGyselinck, Iwein; Liesenborghs, Laurens; Landeloos, Ewout; Belmans , Ann; VERBEKE, Geert; Verhamme, Peter; Vos, Robin; JANSSENS, WimJournal ContributionM
42021Modeling local dependence in latent vector autoregressive modelsDUNG, Tran; LESAFFRE, Emmanuel; VERBEKE, Geert; Duyck, JokeJournal ContributionA1
52021Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trialLiesenborghs , L; Spriet, I; Jochmans, D; Belmans , A; Gyselinck, I; Teuwen, LA; ter Horst, S; Dreesen , E; Geukens , T; Engelen, MM; Landeloos, E; Geldhof, V; Ceunen, H; Debaveye, B; Vandenberk , B; van der Linden , L; Jacobs, S; Langendries , L; Boudewijns, R; Do, TND; Chiu, W; Wang , XY; Zhang, X; Weynand, B; Vanassche, T; Devos , T; Meyfroidt, G; Janssens , W; Vos, R; Vermeersch, P; Wauters, J; VERBEKE, Geert; De Munter , P; Kaptein, SJF; Rocha-Pereira, J; Delang , L; Van Wijngaerden, E; Neyts, J; Verhamme, PJournal ContributionA1
62021Serial correlation structures in latent linear mixed models for analysis of multivariate longitudinal ordinal responsesDUNG, Tran; LESAFFRE, Emmanuel; VERBEKE, Geert; MOLENBERGHS, GeertJournal ContributionA1
72021Latent Ornstein-Uhlenbeck models for Bayesian analysis of multivariate longitudinal categorical responsesDUNG, Tran; LESAFFRE, Emmanuel; VERBEKE, Geert; Duyck, JokeJournal ContributionA1
82021Longitudinal Joint Modelling of Ordinal and Overdispersed Count Outcomes: A Bridge Distribution for the Ordinal Random InterceptAmini, Payam; Moghimbeigi, Abbas; Zayeri, Farid; Tapak, Leili; Maroufizadeh, Saman; VERBEKE, Geert; Kloczkowski, AndrzejJournal ContributionA1